Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Moodys
Johnson and Johnson
Baxter

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)

See Plans and Pricing

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)

Docket   Start Trial Date Filed 2015-05-05
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To
Parties INVENTIA HEALTHCARE LIMITED; INVENTIA HEALTHCARE PVT LTD.; VANDA PHARMACEUTICALS INC.
Patents 8,586,610; 9,138,432
Attorneys Christine A. Dudzik; Constantine Koutsoubas; Daniel J. Klein; Derek James Fahnestock; Douglass C. Hochstetler; Eric A. Stone; Ethan Haller mmTownsend; Ethan Haller Townsend; Jack B. Blumenfeld; Josephine Young; Karen Jacobs; Kira A. Davis; Mark J. Scott; Mary Matterer; Nicholas Groombridge; Sarita M. Matheson
Firms DLA Piper LLP; McDermott Will & Emery LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,586,610;. (els) (Entered: 05… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
0000-00-00 50 Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
0000-00-00 51 Plaintiffs (Nos. 1-16) directed to U.S. Patent No. 8,586,610 filed by Taro Pharmaceutical Industries,… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
0000-00-00 54 Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
0000-00-00 66 Interrogatories to Vanda (Nos. 1-16) Directed To U.S. Patent No. 8,586,610 filed by Vanda Pharmaceuticals Inc..(Fahnestock…Interrogatories to Vanda (Nos. 1-14) Directed to U.S. Patent No. 9,138,432 and (2) Vanda's Objections and Responses… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
0000-00-00 67 Interrogatories to Vanda (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Vanda Pharmaceuticals Inc..(Fahnestock… 5 May 2015 1:15-cv-00362 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
McKinsey
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.